(CNCR) Loncar Cancer - Performance -35.6% in 12m
Compare CNCR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-67.29%
#45 in Group
Rel. Strength
17.43%
#6588 in Universe
Total Return 12m
-35.56%
#45 in Group
Total Return 5y
-51.93%
#46 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: CNCR (-35.6%) vs QQQ (15%)

5y Drawdown (Underwater) Chart

Top Performers in Health
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
PPH NASDAQ VanEck Pharmaceutical |
-1.77% | 0.96% | 60.6% | - | - | - | - | - |
IHE NYSE ARCA iShares U.S. |
-3.33% | 2.25% | 42.6% | - | - | - | - | - |
XLV NYSE ARCA Health Care Sector SPDR |
-4.67% | -1.23% | 51.2% | - | - | - | - | - |
IYH NYSE ARCA iShares U.S. Healthcare |
-4.83% | -2.71% | 44.6% | - | - | - | - | - |
VHT NYSE ARCA Vanguard Health Care |
-3.94% | -1.5% | 44.5% | - | - | - | - | - |
FHLC NYSE ARCA Fidelity MSCI Health Care |
-4.06% | -1.59% | 44.3% | - | - | - | - | - |
IHI NYSE ARCA iShares U.S. Medical |
-1.15% | 8.29% | 44.3% | - | - | - | - | - |
IXJ NYSE ARCA iShares Global Healthcare |
-2.91% | -1.36% | 39.6% | - | - | - | - | - |
Performance Comparison: CNCR vs QQQ vs S&P 500
QQQ (Invesco QQQ Trust ETF) is the Sector Benchmark for CNCR
Total Return (including Dividends) | CNCR | QQQ | S&P 500 |
---|---|---|---|
1 Month | 10.56% | 1.90% | -0.45% |
3 Months | -16.81% | -6.89% | -6.29% |
12 Months | -35.56% | 14.97% | 13.04% |
5 Years | -51.93% | 130.95% | 111.82% |
Trend Score (consistency of price movement) | CNCR | QQQ | S&P 500 |
1 Month | 80.3% | 51.7% | 47.5% |
3 Months | -88.4% | -84.2% | -87.3% |
12 Months | -77.5% | 42.1% | 54.3% |
5 Years | -79.6% | 76.8% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. QQQ | vs. S&P 500 |
1 Month | #4 | 8.49% | 11.1% |
3 Month | #43 | -10.7% | -11.2% |
12 Month | #45 | -44.0% | -43.0% |
5 Years | #46 | -79.2% | -77.3% |
FAQs
Does CNCR Loncar Cancer outperforms the market?
No,
over the last 12 months CNCR made -35.56%, while its related Sector, the Invesco QQQ Trust (QQQ) made 14.97%.
Over the last 3 months CNCR made -16.81%, while QQQ made -6.89%.
Over the last 3 months CNCR made -16.81%, while QQQ made -6.89%.
Performance Comparison CNCR vs Indeces and Sectors
CNCR vs. Indices CNCR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -4.22% | 11.0% | -30.9% | -48.6% |
US NASDAQ 100 | QQQ | -5.14% | 8.66% | -31.6% | -50.5% |
US Dow Jones Industrial 30 | DIA | -3.68% | 13.4% | -30.2% | -44.8% |
German DAX 40 | DAX | -3.86% | 10.8% | -49.0% | -60.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.57% | 13.8% | -27.2% | -40.5% |
Hongkong Hang Seng | HSI | -3.82% | 12.1% | -31.5% | -48.5% |
India NIFTY 50 | INDA | -1.70% | 5.68% | -30.8% | -38.5% |
Brasil Bovespa | EWZ | -2.59% | 7.73% | -36.6% | -28.8% |
CNCR vs. Sectors CNCR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -4.37% | 11.2% | -36.9% | -59.0% |
Consumer Discretionary | XLY | -4.25% | 11.2% | -32.1% | -50.2% |
Consumer Staples | XLP | -2.16% | 11.4% | -35.0% | -46.5% |
Energy | XLE | 0.04% | 24.6% | -25.8% | -26.2% |
Financial | XLF | -3.11% | 12.6% | -37.9% | -58.2% |
Health Care | XLV | -1.52% | 15.2% | -25.8% | -34.3% |
Industrial | XLI | -4.54% | 10.3% | -32.0% | -46.3% |
Materials | XLB | -2.41% | 13.8% | -23.1% | -31.1% |
Real Estate | XLRE | -4.11% | 11.7% | -31.1% | -53.9% |
Technology | XLK | -5.78% | 8.13% | -28.0% | -46.0% |
Utilities | XLU | -2.94% | 10.5% | -35.3% | -56.4% |
Aerospace & Defense | XAR | -5.25% | 3.58% | -44.8% | -63.0% |
Biotech | XBI | -4.06% | 5.01% | -15.6% | -30.2% |
Homebuilder | XHB | -2.95% | 12.6% | -16.0% | -29.4% |
Retail | XRT | -2.98% | 11.7% | -25.0% | -34.1% |